Anbio Biotechnology (NASDAQ:NNNN) Shares Up 7.1% – Time to Buy?

Shares of Anbio Biotechnology (NASDAQ:NNNN) rose 7.1% during mid-day trading on Thursday . The company traded as high as $13.47 and last traded at $13.2250. 22,403 shares traded hands during mid-day trading, a decline of 50% from the average session volume of 44,764 shares. The stock had previously closed at $12.35.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded shares of Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, May 14th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company has a consensus rating of “Hold”.

Anbio Biotechnology Price Performance

The stock has a fifty day simple moving average of $24.04.

Anbio Biotechnology (NASDAQ:NNNN) last announced its quarterly earnings data on Tuesday, April 7th. The company reported $0.03 earnings per share (EPS) for the quarter.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.